NCT00764387 - Contrast Enhanced MRI of the CNS - Patients With Known Cerebral Neoplastic Lesions. | Biotech Hunter

Enrollment

166

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions

Neoplastic CNS Lesions

Interventions

DRUG

Gadovist® (Gadobutrol, BAY86-4875)

0,1 mmol/kg of body weight in the vein, single administration

DRUG

Dotarem

0,1 mmol/kg of body weight in the vein, single administration

Trial Locations (12)

Milan

Novara

Trieste

Verona

Siena

Chieti

Andria

Napoli

Catania

Messina

Roma

Roma